KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 133 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,508,850 | +9.8% | 605,000 | -11.0% | 0.04% | -41.4% |
| Q2 2023 | $9,574,400 | -39.8% | 680,000 | -54.0% | 0.07% | +1.4% |
| Q1 2023 | $15,891,347 | +76.8% | 1,476,891 | +146.1% | 0.07% | -25.0% |
| Q4 2022 | $8,988,000 | -41.7% | 600,000 | -50.0% | 0.09% | -32.4% |
| Q3 2022 | $15,408,000 | +15.6% | 1,200,000 | -12.7% | 0.14% | +34.7% |
| Q2 2022 | $13,324,000 | +4.7% | 1,375,000 | +7.4% | 0.10% | -41.3% |
| Q1 2022 | $12,723,000 | +3.0% | 1,280,000 | +21.9% | 0.17% | +36.5% |
| Q4 2021 | $12,358,000 | -5.7% | 1,050,000 | -8.7% | 0.13% | -29.2% |
| Q3 2021 | $13,099,000 | +17.5% | 1,150,000 | +43.8% | 0.18% | +31.9% |
| Q2 2021 | $11,144,000 | +21.6% | 800,000 | +61.6% | 0.14% | +19.5% |
| Q1 2021 | $9,162,000 | -56.8% | 495,000 | -58.8% | 0.11% | -0.9% |
| Q4 2020 | $21,204,000 | +207.6% | 1,200,000 | +166.7% | 0.11% | +10.7% |
| Q3 2020 | $6,894,000 | +46.3% | 450,000 | +143.2% | 0.10% | +25.6% |
| Q2 2020 | $4,713,000 | +32.4% | 185,000 | -19.6% | 0.08% | -7.9% |
| Q1 2020 | $3,560,000 | -26.8% | 230,000 | -47.7% | 0.09% | -17.6% |
| Q4 2019 | $4,866,000 | +340.0% | 440,000 | +238.5% | 0.11% | +248.4% |
| Q3 2019 | $1,106,000 | -29.0% | 130,000 | +13.0% | 0.03% | -13.9% |
| Q2 2019 | $1,557,000 | -4.2% | 115,000 | +27.8% | 0.04% | +71.4% |
| Q1 2019 | $1,625,000 | – | 90,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |